Renal osteodystrophy and aging.
The bone disease seen in our aging dialysis population is a complex mixture of osteoporosis and renal osteodystrophy. Attention must be paid to both of these issues. Hip fractures are increased with aging and this increase is further aggravated by renal failure. Preventive management with Vitamin D and bisphosphonates is reviewed.
Sherrard
Donald J
DJ
VA Medical Center and University of Washington, Seattle, WA 98108, USA. sherrard@u.washington.edu
D000368:Aged; D000375:Aging; D050071:Bone Density Conservation Agents / Q000009:adverse effects; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000150:complications*; D004164:Diphosphonates / Q000009:adverse effects; D005081:Exercise Therapy; D005260:Female; D006620:Hip Fractures / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D014807:Vitamin D / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D014807:Vitamin D